Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,358 stories, page 192 of 623

Advanced search

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07784179: Ultrasound and Photoacoustic Imaging of Hydrocephalus in Pediatric Patients

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07781683: Clinical Evaluation of Salivary 1,5-Anhydroglucitol in Diabetes

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07766018: A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07756294: Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07743580: A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07633158: Prospective, Non-interventional Single-arm Study With Tezepelumab to Investigate the Change in Clinical and Patient-reported Outcomes in Patients With CRSwNP in Real-world (PETRICHOR)

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07619534: Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07605949: Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07601074: A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07599670: A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07579208: A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07579195: Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07407738: ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07378644: Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07154290: A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07076615: The Effect of Dapagliflozin on Patients With Cardiomyopathy

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT07013474: A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT06820476: A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT06807385: The Effect of the Reaction Training in Parkinson's Disease

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT06804499: Tampere Coronary Artery Disease and Sudden Cardiac Arrest Study

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT06545682: Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT06514261: Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT06289556: Clinical Performance of Masimo INVSENSOR00048

Study type: INTERVENTIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT06059638: BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT05652504: Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT05348356: Nirogacestat in Ovarian Granulosa Cell Tumors

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT05099003: A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT04626791: Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT04565743: Stop At One Stockholm (SAOS)- Secondary Fracture Prevention Through Active Patient Identification and Staff Education.

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT04493164: CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT04419870: Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT04181060: Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT04136171: CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT01216371: Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 25Researchclinicaltrials.govTier 1 · Trial registry

NCT00899301: Collecting and Storing Tissue Samples From Women With or Without Breast Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Adar1 Capital Management buys $1.8m of Tenax Therapeutics (TENX) shares

Investing.comOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Competition or collusion: Entry decisions in the Swedish pharmaceutical market

CEPROriginal source

🌍Aug 25discoverynews.google.comTier 2 · Trade media

Roche outlays $2.3bn for Hanmi’s non-GLP-1 obesity candidate

Pharmaceutical TechnologyOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

DOJ Backs Biotech Co. Against Red Cross At 1st Circ.

Law360Original source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Top Biopharma Analyst Sees Biotech M&A Market Reopening After a Long Freeze

24/7 Wall St.Original source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Allied Biotech Corp – TPEX:1780

TradingViewOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Collegium CEO is moving the biotech firm to Boston from the suburbs

The Boston GlobeOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Central Bucks Chamber Moves From Swamp Road to the Biotech Campus

Lower Bucks TimesOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Australian study finds maternal RSV vaccination offers strong protection for infants

PharmaDispatchOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

New Drug, ANS-858, Aims To Reduce Alcohol And Drug Cravings

Addiction CenterOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

3 Firms Build Biotech Merger With $150M In Private Funding

Law360Original source

🌍Aug 25discoverynews.google.comTier 2 · Trade media

Cellares, a cell therapy manufacturing specialist, to lay off 100 employees

BioPharma DiveOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Biotech Firm Nears 700K-SF Lease at Former Google Hub

Connect CREOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

FDA SIDE EFFECTS UPDATE: New Allergic Reaction Warnings for Osteoporosis and Hypoparathyroidism Drugs

MedShadow FoundationOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Creative Medical completes Olastrocel trial enrollment as it sets sights on FDA Phase 3 path

Indian Pharma PostOriginal source

🌍Aug 25discoverynews.google.comTier 2 · Trade media

Finding the Invisible: AI for Rare Disease Patient Identification

Fierce BiotechOriginal source

🌍Aug 25Industrycibeles.com.uyTier 1 · Company source

Nutrición

Cibeles (Uruguay)Original source

🌍Aug 25Industrycibeles.com.uyTier 1 · Company source

Xistrovin 25sc

Cibeles (Uruguay)Original source

🌍Aug 25Industrycibeles.com.uyTier 1 · Company source

XISTROVIN 25SC

Cibeles (Uruguay)Original source

🌍Aug 25Industrycibeles.com.uyTier 1 · Company source

RYNAGEN 200SC

Cibeles (Uruguay)Original source

🌍Aug 25Industrycibeles.com.uyTier 1 · Company source

Rynagen 200sc

Cibeles (Uruguay)Original source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026

Yahoo FinanceOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical sciences professor publishes two books

Campbell University NewsOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

New lease on life-sciences? Biotech takes 700K sf at former Google campus in Redwood City

The Real DealOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Hanmi Licenses HM17321 to Genentech | PharmExec

Pharmaceutical ExecutiveOriginal source